Associations - GNA11 mutation

GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	selumetinib Sensitive: C2 – Inclusion Criteria	selumetinib Sensitive: C2 – Inclusion Criteria
GNA11 mutation GNA11 mutation	Melanoma Melanoma	GNA11 mutation GNA11 mutation	Melanoma Melanoma	vorinostat Sensitive: C2 – Inclusion Criteria	vorinostat Sensitive: C2 – Inclusion Criteria
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	pembrolizumab Sensitive: C3 – Early Trials	pembrolizumab Sensitive: C3 – Early Trials
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	AEB071 Sensitive: C3 – Early Trials	AEB071 Sensitive: C3 – Early Trials
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	cabozantinib capsule Sensitive: C3 – Early Trials	cabozantinib capsule Sensitive: C3 – Early Trials
GNA11 mutation GNA11 mutation	Non Small Cell Lung Cancer NSCLC	GNA11 mutation GNA11 mutation	Non Small Cell Lung Cancer NSCLC	nivolumab Resistant: C3 – Early Trials	nivolumab Resistant: C3 – Early Trials
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	AEB071 + AHT956 Sensitive: D – Preclinical	AEB071 + AHT956 Sensitive: D – Preclinical
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	FR900359 Sensitive: D – Preclinical	FR900359 Sensitive: D – Preclinical
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	binimetinib + AEB071 Sensitive: D – Preclinical	binimetinib + AEB071 Sensitive: D – Preclinical
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	verteporfin Sensitive: D – Preclinical	verteporfin Sensitive: D – Preclinical
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	AEB071 + CGM097 Sensitive: D – Preclinical	AEB071 + CGM097 Sensitive: D – Preclinical
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	everolimus + AEB071 Sensitive: D – Preclinical	everolimus + AEB071 Sensitive: D – Preclinical
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	JQ-1 Sensitive: D – Preclinical	JQ-1 Sensitive: D – Preclinical
GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	GNA11 mutation GNA11 mutation	Uveal Melanoma Uveal Melanoma	PD-0325901 + AEB071 Sensitive: D – Preclinical	PD-0325901 + AEB071 Sensitive: D – Preclinical